A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

A three-drug combination targeting aggressive advanced breast cancer could potentially ... protein – as well as the hormone therapy fulvestrant. The placebo group, which included 164 patients, were ...

A three-drug combination targeting aggressive advanced breast cancer ... the hormone therapy fulvestrant. The placebo group, which included 164 patients, were given a placebo plus palbociclib ...

plus get all your favorite TechRadar content. First up this month is the Dead Space remake for PS5. The sci-fi survival horror classic returns, rebuilt to offer a deeper and more immersive experience.

BingoPlus Foundation partnered with the Philippine Foundation for Breast Care (Kasuso Foundation) to launch a PLUS e-Center to bridge remote work opportunities for breast cancer survivors and ...

So, question, is it really “survival” if you are the one putting ... and they won’t hesitate to kill you. Plus, there’s the “No Return” mode that was made specifically for the newly ...

This industry symposium took place during the European Society for Medical Oncology (ESMO) Congress held in Barcelona, Spain, from 13 th –17 th September 2024. Schmid has received consulting fees from ...

This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4/6i) ...